Site News July 2016
Yahoo Finance recently redesigned their site. In my opinion, it’s a usability nightmare. Information is less dense. The right side bar is filled with poorly designed graphs (e.g. the earnings estimates graph takes up...
Analytics for Pharma and Biotech Traders
Yahoo Finance recently redesigned their site. In my opinion, it’s a usability nightmare. Information is less dense. The right side bar is filled with poorly designed graphs (e.g. the earnings estimates graph takes up...
This is a list of Phase 3 trials with primary completion dates in July 2016 for companies with a market cap less than $1B. For complete clinical trial coverage, please see our Trial Tracker...
This is a list of Phase 3 trials with primary completion dates in June 2016 for companies with a market cap less than $1B. For complete clinical trial coverage, please see our Trial Tracker...
A long overdue update this month: the Adcom Explorer database now covers FDA advisory committee results through April 12, 2016.
This is a list of Phase 3 trials with primary completion dates in May 2016 for companies with a market cap less than $1B. For complete clinical trial coverage, please see our Trial Tracker...
This is a list of Phase 3 trials with primary completion dates in April 2016 for companies with a market cap less than $1B. For complete clinical trial coverage, please see our Trial Tracker...
This is a list of Phase 3 trials with primary completion dates in March 2016 for companies with a market cap less than $1B. For complete clinical trial coverage, please see our Trial Tracker...
This is a list of Phase 3 trials with primary completion dates in February 2016 for companies with a market cap less than $1B. For complete clinical trial coverage, please see our Trial Tracker...
This is a list of Phase 3 trials with primary completion dates in January 2016 for companies with a market cap less than $1B. For complete clinical trial coverage, please see our Trial Tracker...
This is a list of Phase 3 trials with primary completion dates in December 2015 for companies with a market cap less than $1B. For complete clinical trial coverage, please see our Trial Tracker...